SARCLISA FDA approval date

The FDA approved SARCLISA on 2 Mar 2020.

FDA approval date
2 Mar 2020

Drug identity has not yet been verified against registry records

Also recorded as ISATUXIMAB-IRFC

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2020-03-02DaySARCLISAFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA761113", "applicant_as_listed_by_fda": "SANOFI AVENTIS US", "brand_names": ["SARCLISA"], "active_ingredients": ["ISATUXIMAB-IRFC"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20200302", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026